Brief: Medrx says drug development and sale contract change
23/03/2018 06:38
March 23(Reuters) - Medrx Co Ltd 4586.T
* Says it enters into a license contract with Cipla Ltd's
wholly
owned unit Cipla Technologies, LLC, instead of with Cipla Ltd's
wholly owned unit Cipla USA Inc preciously, on development and
sale of MRX-4TZT, transdermal patch for the treatment of spastic
paralysis, due to Cipla group' s reorganization
* Says previous press was disclosed on April 6, 2017
Source text in Japanese:https://goo.gl/vEFmrv
Further company coverage: 4586.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))